These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2487913)

  • 1. Fetal and neonatal immunoincompetence.
    Vetro SW; Bellanti JA
    Fetal Ther; 1989; 4 Suppl 1():82-91. PubMed ID: 2487913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allogeneic lymphocytes exerted graft-versus-host rather than tolerogenic effects on preimmune fetuses.
    Chen JC; Ou LS; Yu HY; Chang HL; Chang PY; Kuo ML
    J Surg Res; 2013 Jul; 183(1):405-11. PubMed ID: 23295194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal tolerance induction in diabetes-prone BB rats as a model for donor-specific pancreas transplantation during adulthood.
    Nakai I; Oka T; Field JM; Najarian JS; Sutherland DE; Brayman KL
    Transplant Proc; 1992 Dec; 24(6):2902. PubMed ID: 1465991
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunological Consequences of
    Chen JC
    Front Immunol; 2021; 12():638435. PubMed ID: 33936052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerance, immunocompetence, and secondary disease in fully allogeneic radiation chimeras.
    Rayfield LS; Brent L
    Transplantation; 1983 Aug; 36(2):183-9. PubMed ID: 6349042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of lymphokine-activated killer cells to prevent bone marrow graft rejection and lethal graft-vs-host disease.
    Azuma E; Yamamoto H; Kaplan J
    J Immunol; 1989 Sep; 143(5):1524-9. PubMed ID: 2668409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligation of 4-1BB (CDw137) regulates graft-versus-host disease, graft-versus-leukemia, and graft rejection in allogeneic bone marrow transplant recipients.
    Blazar BR; Kwon BS; Panoskaltsis-Mortari A; Kwak KB; Peschon JJ; Taylor PA
    J Immunol; 2001 Mar; 166(5):3174-83. PubMed ID: 11207270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donor double-negative Treg promote allogeneic mixed chimerism and tolerance.
    He KM; Ma Y; Wang S; Min WP; Zhong R; Jevnikar A; Zhang ZX
    Eur J Immunol; 2007 Dec; 37(12):3455-66. PubMed ID: 18000953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.
    Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S
    J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innate immunity of the newborn: basic mechanisms and clinical correlates.
    Levy O
    Nat Rev Immunol; 2007 May; 7(5):379-90. PubMed ID: 17457344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural mechanisms for evading graft rejection: the fetus as an allograft.
    Koch CA; Platt JL
    Springer Semin Immunopathol; 2003 Sep; 25(2):95-117. PubMed ID: 12955462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fetal and neonatal immunology.
    Ciccimarra F
    J Perinat Med; 1994; 22 Suppl 1():84-7. PubMed ID: 7932010
    [No Abstract]   [Full Text] [Related]  

  • 13. Graft-versus-host reactivity and graft-versus-leukemia effect in murine allogeneic bone marrow chimeras conditioned with total body irradiation or total lymphoid irradiation.
    Salam A; Waer M
    Transplantation; 1996 Mar; 61(5):826-30. PubMed ID: 8607190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunologic problems in allogenic and autologous bone marrow transplantation].
    Schwenke H; Helbig W; Kubel M; Schultze W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(2):217-23. PubMed ID: 6208106
    [No Abstract]   [Full Text] [Related]  

  • 15. In vivo administration of interleukin-6 in murine allogeneic bone marrow chimeras: early and delayed enhancement of hematopoiesis accompanied with split tolerance but not with graft-versus-host disease.
    Imamura M; Hashino S; Kobayashi H; Tanaka J; Imai K; Han M; Fujii Y; Kobayashi M; Higa T; Kasai M
    Immunobiology; 1994 Jun; 190(4-5):346-67. PubMed ID: 7982720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancy and the immune system: between tolerance and rejection.
    Thellin O; Heinen E
    Toxicology; 2003 Apr; 185(3):179-84. PubMed ID: 12581692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologic, clinical, and pathologic aspects of human graft-versus-host disease.
    Wick MR; Moore SB; Gastineau DA; Hoagland HC
    Mayo Clin Proc; 1983 Sep; 58(9):603-12. PubMed ID: 6350737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural suppressor cells.
    Maier T; Holda JH; Claman HN
    Prog Clin Biol Res; 1989; 288():235-44. PubMed ID: 2524070
    [No Abstract]   [Full Text] [Related]  

  • 19. Gammadelta T cells do not require fully functional cytotoxic pathways or the ability to recognize recipient alloantigens to prevent graft rejection.
    Vodanovic-Jankovic S; Drobyski WR
    Biol Blood Marrow Transplant; 2006 Nov; 12(11):1125-34. PubMed ID: 17085305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What can be done to prevent graft versus host disease?
    Waldmann H; Cobbold S; Hale G
    Curr Opin Immunol; 1994 Oct; 6(5):777-83. PubMed ID: 7826534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.